BRPI0512025A - usos antiparasìticos de complexos de ácido borìnico - Google Patents

usos antiparasìticos de complexos de ácido borìnico

Info

Publication number
BRPI0512025A
BRPI0512025A BRPI0512025-0A BRPI0512025A BRPI0512025A BR PI0512025 A BRPI0512025 A BR PI0512025A BR PI0512025 A BRPI0512025 A BR PI0512025A BR PI0512025 A BRPI0512025 A BR PI0512025A
Authority
BR
Brazil
Prior art keywords
acid complexes
boronic acid
antiparasitic
antiparasitic uses
borinic acid
Prior art date
Application number
BRPI0512025-0A
Other languages
English (en)
Inventor
Carolyn Bellinger-Kawahara
Kirk R Maples
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of BRPI0512025A publication Critical patent/BRPI0512025A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

USOS ANTIPARASìTICOS DE COMPLEXOS DE áCIDO BORìNICO São descritas composições e métodos de uso de complexos de ácido borínico, especialmente hidroxiquinolina, imidazol e derivados de ácido picolínico, como agentes antiparasíticos bem como agentes terapêuticas para o tratamento de doenças causadas por parasitas.
BRPI0512025-0A 2004-06-14 2005-06-14 usos antiparasìticos de complexos de ácido borìnico BRPI0512025A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57947604P 2004-06-14 2004-06-14
PCT/US2005/021219 WO2005123095A1 (en) 2004-06-14 2005-06-14 Anti-parasitic uses of borinic acid complexes

Publications (1)

Publication Number Publication Date
BRPI0512025A true BRPI0512025A (pt) 2008-02-06

Family

ID=34979015

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512025-0A BRPI0512025A (pt) 2004-06-14 2005-06-14 usos antiparasìticos de complexos de ácido borìnico

Country Status (9)

Country Link
US (1) US20060014723A1 (pt)
EP (1) EP1771182A1 (pt)
JP (1) JP2008502702A (pt)
AR (1) AR049916A1 (pt)
BR (1) BRPI0512025A (pt)
CA (1) CA2570534A1 (pt)
MX (1) MXPA06014414A (pt)
TW (1) TW200610530A (pt)
WO (1) WO2005123095A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2654449A1 (en) * 2006-06-12 2007-12-21 Anacor Pharmaceuticals, Inc. Compounds for the treatment of periodontal disease
US8853424B2 (en) 2008-08-11 2014-10-07 Japan Science And Technology Agency Protein cross-linking inhibitor
KR20110063583A (ko) 2008-10-02 2011-06-10 바스프 에스이 착염
KR101756785B1 (ko) 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
CN111995634B (zh) * 2020-08-28 2022-08-05 深圳大学 一种四配位有机硼化合物、荧光探针及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348948A (en) * 1993-05-07 1994-09-20 American Cyanamid Company 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
US5348947A (en) * 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US5574017A (en) * 1994-07-05 1996-11-12 Gutheil; William G. Antibacterial agents
WO2000044387A1 (fr) * 1999-01-29 2000-08-03 Nitto Kasei Co., Ltd. Composes organobores presentant une activite de coccidiostats
DE10110051C2 (de) * 2001-03-02 2003-07-03 Clariant Gmbh Verfahren zur Herstellung von Boron- und Borinsäuren
US7390806B2 (en) * 2002-12-18 2008-06-24 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use
EP1581500A4 (en) * 2002-12-18 2008-03-05 Anacor Pharmaceuticals Inc ANTIBIOTICS CONTAINING BORINIC ACID COMPLEXES AND METHOD OF USE

Also Published As

Publication number Publication date
AR049916A1 (es) 2006-09-13
CA2570534A1 (en) 2005-12-29
MXPA06014414A (es) 2007-03-08
US20060014723A1 (en) 2006-01-19
JP2008502702A (ja) 2008-01-31
WO2005123095A1 (en) 2005-12-29
EP1771182A1 (en) 2007-04-11
TW200610530A (en) 2006-04-01

Similar Documents

Publication Publication Date Title
BRPI0512049A (pt) usos antivirais de complexos de ácido borìnico
BRPI0512108A (pt) antibióticos contendo complexos de ácido borìnico e métodos de uso
CO6351786A2 (es) Inkibidores de la cinasa map p38
HK1091731A1 (en) Pharmaceutical use of fused heterocyclic compounds as scce inhibitors for the treatment of skin conditions or cancer
CR20110230A (es) Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38
HK1096392A1 (en) Substituted heterocycles
MX2011010673A (es) Formulaciones de nanoparticulas y usos de las mismas.
BR0317564A (pt) Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos
EA200800555A1 (ru) Производные ксантина в качестве селективных агонистов hm74a
NO20070782L (no) Tetrapeptidanaloger.
TW200606162A (en) Pyrazolopyridine derivatives
ATE387450T1 (de) Meso-substituierte porphyrine
BR0206161A (pt) 2-fenil benzimidazóis e imidazo-[4,5]-piridinas como inibidores de cds1/chk2 e adjuvantes para quimioterapia ou terapia por radiação no tratamento de câncer
MX2010010505A (es) Imidazoquinolinas y derivados de pirimidina como moduladores potentes de los procesos angiogenicos impulsados por el factor de crecimiento endotelial vascular (vegf).
UY29046A1 (es) Derivados de n-(1h-indolil)-1h-indol-2-carboxamidas, su preparación y su uso en terapia
ATE453646T1 (de) 3-substituierte n-(aryl- oder heteroaryl)pyrazoä1,5-aüpyrimidine als kinaseinhibitoren
MXPA05011076A (es) Derivados de quinazolina para el tratamiento de cancer.
BRPI0512025A (pt) usos antiparasìticos de complexos de ácido borìnico
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
SE0300457D0 (sv) Novel compounds
WO2014029888A3 (en) Branched or macrocyclic polyamines and uses thereof
ATE531698T1 (de) 4-aminocarbonylamino-substitutierte imidazolverbindungen mit antiviraler wirkung
ATE553088T1 (de) Substituierte chinolone ii

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.